Radiation-induced lung injury: current evidence
M Arroyo-Hernández, F Maldonado… - BMC pulmonary …, 2021 - Springer
Chemo-radiotherapy and systemic therapies have proven satisfactory outcomes as standard
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …
Radiation-induced lung injury (RILI)
L Giuranno, J Ient, D De Ruysscher, MA Vooijs - Frontiers in oncology, 2019 - frontiersin.org
Radiation pneumonitis (RP) and radiation fibrosis (RF) are two dose-limiting toxicities of
radiotherapy (RT), especially for lung, and esophageal cancer. It occurs in 5–20% of …
radiotherapy (RT), especially for lung, and esophageal cancer. It occurs in 5–20% of …
[HTML][HTML] Targeting senescence-like fibroblasts radiosensitizes non–small cell lung cancer and reduces radiation-induced pulmonary fibrosis
J Meng, Y Li, C Wan, Y Sun, X Dai, J Huang, Y Hu… - JCI insight, 2021 - ncbi.nlm.nih.gov
Cancer cell radioresistance is the primary cause of the decreased curability of non–small
cell lung cancer (NSCLC) observed in patients receiving definitive radiotherapy (RT) …
cell lung cancer (NSCLC) observed in patients receiving definitive radiotherapy (RT) …
Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention
V Mehta - International journal of radiation oncology* biology …, 2005 - Elsevier
Although radiotherapy improves locoregional control and survival in patients with non-small-
cell lung cancer, radiation pneumonitis is a common treatment-related toxicity. Many …
cell lung cancer, radiation pneumonitis is a common treatment-related toxicity. Many …
A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis
IR Vogelius, SM Bentzen - Acta oncologica, 2012 - Taylor & Francis
Introduction. The risk of developing side effects after radiotherapy is not only dependent on
radiation dose, but may also be affected by patient-related risk factors. Here we perform a …
radiation dose, but may also be affected by patient-related risk factors. Here we perform a …
[HTML][HTML] Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review
Y Yan, J Fu, RO Kowalchuk, CM Wright… - … lung cancer research, 2022 - ncbi.nlm.nih.gov
Methods PubMed was used to collect articles about RILI from 1995 to 2021. The papers
included clinical trials, reviews, as well as systematic reviews and meta-analyses. Based on …
included clinical trials, reviews, as well as systematic reviews and meta-analyses. Based on …
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with …
S Wang, Z Liao, X Wei, HH Liu, SL Tucker, C Hu… - International Journal of …, 2006 - Elsevier
Purpose: To investigate factors associated with treatment-related pneumonitis in non–small-
cell lung cancer patients treated with concurrent chemoradiotherapy. Patients and Methods …
cell lung cancer patients treated with concurrent chemoradiotherapy. Patients and Methods …
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective
M Cremonesi, C Chiesa, L Strigari, M Ferrari… - Frontiers in …, 2014 - frontiersin.org
Radioembolization (RE) of liver cancer with 90Y-microspheres has been applied in the last
two decades with notable responses and acceptable toxicity. Two types of microspheres are …
two decades with notable responses and acceptable toxicity. Two types of microspheres are …
Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
Purpose: We aimed to report the final toxicity results on a radiation-dose escalation trial
designed to test a hypothesis that very high doses of radiation could be safely administered …
designed to test a hypothesis that very high doses of radiation could be safely administered …
Initial evaluation of treatment-related pneumonitis in advanced-stage non–small-cell lung cancer patients treated with concurrent chemotherapy and intensity …
SS Yom, Z Liao, HH Liu, SL Tucker, CS Hu… - International Journal of …, 2007 - Elsevier
PURPOSE: To investigate the rate of high-grade treatment-related pneumonitis (TRP) in
patients with advanced non–small-cell lung cancer (NSCLC) treated with concurrent …
patients with advanced non–small-cell lung cancer (NSCLC) treated with concurrent …